Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease

• Richard J. Perrin ,

  Contributed equally to this work with: Richard J. Perrin, Rebecca Craig-Schapiro

  * E-mail: rperrin@path.wustl.edu

  Affiliations Division of Neuropathology, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America, Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Rebecca Craig-Schapiro ,

  Contributed equally to this work with: Richard J. Perrin, Rebecca Craig-Schapiro

  Affiliation Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• James P. Malone,

  Affiliations Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America, Division of Metabolism and Proteomics Center, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Aarti R. Shah,

  Affiliation Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Petra Gilmore,

  Affiliations Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America, Division of Metabolism and Proteomics Center, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Alan E. Davis,

  Affiliations Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America, Division of Metabolism and Proteomics Center, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Catherine M. Roe,

  Affiliations Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Elaine R. Peskind,

  Affiliations Department of Veterans Affairs Northwest Network Mental Illness Research, Education, and Clinical Center, University of Washington School of Medicine, Seattle, Washington, United States of America, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington, United States of America

  ⨯
• Ge Li,

  Affiliation Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington, United States of America

  ⨯
• Douglas R. Galasko,

  Affiliation Department of Neurosciences, University of California at San Diego, San Diego, California, United States of America

  ⨯
• Christopher M. Clark,

  Affiliations Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Alzheimer's Disease Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Avid Radiopharmaceuticals, Philadelphia, Pennsylvania, United States of America

  ⨯
• Joseph F. Quinn,

  Affiliation Layton Aging and Alzheimer's Disease Center, Oregon Health Science University, Portland, Oregon, United States of America

  ⨯
• Jeffrey A. Kaye,

  Affiliation Layton Aging and Alzheimer's Disease Center, Oregon Health Science University, Portland, Oregon, United States of America

  ⨯
• John C. Morris,

  Affiliations Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America, Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• David M. Holtzman,

  Affiliations Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America, Division of Metabolism and Proteomics Center, Washington University School of Medicine, St. Louis, Missouri, United States of America, Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• R. Reid Townsend,

  Affiliations Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America, Division of Metabolism and Proteomics Center, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
•  [ ... ],
• Anne M. Fagan

  Affiliations Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America, Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• [ view all ]
• [ view less ]